Skip to main content

Table 2 Patient characteristics and association with dialysis modality

From: Long-term survival and predictors for mortality among dialysis patients in an endemic area for chronic liver disease: a national cohort study in Taiwan

  PD (n = 761) HD (n = 11293) P-value
  n (%) n (%)  
Gender      0.004
Female 445 (58.50) 5997 (53.10)  
Male 316 (41.50) 5296 (46.90)  
Age (years)      <0.001
18-44 217 (28.50) 1584 (14.00)  
45-64 347 (45.60) 5067 (44.90)  
≥65 197 (25.90) 4642 (41.10)  
Cause of ESRD      <0.001
Non-Diabetes Mellitus 478 (62.80) 5471 (48.40)  
Diabetes Mellitus 283 (37.20) 5822 (51.60)  
Baseline Comorbidity      
Hypertension      0.548
No 187 (24.60) 2667 (23.60)  
Yes 574 (75.40) 8626 (76.40)  
Congestive Heart Failure      <0.001
No 567 (86.30) 9172 (81.20)  
Yes 104 (13.70) 2121 (18.80)  
Coronary Artery Disease      0.01
No 614 (80.70) 8655 (76.60)  
Yes 147 (19.30) 2638 (23.40)  
Cerebrovascular Disease      0.002
No 698 (91.70) 9224 (87.90)  
Yes 63 (8.30) 1369 (12.10)  
Peripheral Arterial Disease      0.152
No 740 (97.20) 10867 (96.20)  
Yes 21 (2.80) 426 (3.80)  
Chronic Lung Disease      <0.001
No 716 (94.10) 10094 (89.40)  
Yes 45 (5.90) 1199 (10.60)  
Liver Cirrhosis      0.282
No 721 (94.70) 10590 (93.80)  
Yes 40 (5.30) 703 (6.20)  
Cancer      0.46
No 741 (97.40) 10831 (95.90)  
Yes 20 (2.60) 462 (4.10)  
Dementia      0.072
No 757 (99.50) 11150 (98.70)  
Yes 5 (0.50) 143 (1.30)  
Hemiplegia or Paraplegia      0.785
No 750 (98.60) 11143 (98.70)  
Yes 11 (1.40) 150 (1.30)  
  1. PD: Peritoneal dialysis; HD: Hemodialysis; ESRD: End-stage renal disease.